ChartRow logo
TEVA
Teva Pharmaceutical Industries Limited American Depositary SharesStock · Health Care
$34.81+$0.09 (+0.26%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

TEVA financial statements

The full income statement, balance sheet, and cash-flow statement for Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 1.13B2024-09 1.13B2024-12 1.13B2025-03 1.15B2025-06 1.15B2025-09 1.15B2025-12 1.15B2026-03 1.16B2026-06 1.17B+2.9% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
17.3B
YoY+4.3%
16.5B
YoY+4.4%
15.8B
YoY+6.2%
14.9B
YoY-6.0%
15.9B
YoY-4.7%
8.94B
YoY+10.8%
8.06B
YoY+5.5%
7.64B
YoY+9.6%
6.97B
YoY-8.2%
7.59B
YoY-1.7%
Research & development
1.01B
YoY+1.5%
998M
YoY+4.7%
953M
YoY+872.4%
98.0M
YoY-89.9%
967M
YoY-3.0%
Selling, general & administrative
1.29B
YoY+10.9%
1.16B
YoY-0.1%
1.16B
YoY-1.5%
1.18B
YoY+7.4%
1.10B
YoY-6.3%
General & administrative
1.29B
YoY+10.9%
1.16B
YoY-0.1%
1.16B
YoY-1.5%
1.18B
YoY+7.4%
1.10B
YoY-6.3%
Selling & marketing
2.69B
YoY+5.7%
2.54B
YoY+8.8%
2.34B
YoY+3.1%
2.27B
YoY-6.8%
2.43B
YoY-2.8%
Restructuring
225M
YoY+204.1%
74.0M
YoY-33.3%
111M
YoY-24.0%
146M
YoY+9.8%
133M
YoY+10.8%
Amortization of intangibles
581M
YoY-1.2%
588M
YoY-4.5%
616M
YoY-15.8%
732M
YoY-8.7%
802M
YoY-21.4%
Operating income
2.16B
YoY+811.9%
-303M
YoY-170.0%
433M
YoY+119.7%
-2.20B
YoY-228.0%
1.72B
YoY+148.0%
Interest expense
916M
YoY-8.6%
1.00B
YoY-2.6%
1.03B
YoY+10.6%
930M
YoY+4.4%
891M
YoY-1.1%
Other non-operating income
-934M
YoY+4.8%
-981M
YoY+7.2%
-1.06B
YoY-9.4%
-966M
YoY+8.7%
-1.06B
YoY-26.9%
Equity-method income
15.0M
YoY+1400.0%
1.00M
YoY-50.0%
2.00M
YoY-90.5%
21.0M
YoY+133.3%
9.00M
YoY-93.5%
Pre-tax income
1.22B
YoY+195.2%
-1.28B
YoY-105.8%
-624M
YoY+80.3%
-3.16B
YoY-580.7%
658M
YoY+114.9%
Income tax
-180M
YoY-126.6%
676M
YoY+9757.1%
-7.00M
YoY+98.9%
-643M
YoY-404.7%
211M
YoY+225.6%
1.41B
YoY+186.0%
-1.64B
YoY-193.2%
-559M
YoY+77.1%
-2.45B
YoY-686.6%
417M
YoY+110.5%
$1.21
YoY+183.4%
-$1.45
YoY-190.0%
-$0.50
YoY+77.3%
-$2.20
YoY-678.9%
$0.38
YoY+110.4%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
13.9B
YoY+11.1%
12.6B
YoY+0.5%
12.5B
YoY+3.6%
12.1B
YoY-4.2%
12.6B
YoY-3.3%
40.7B
YoY+3.6%
39.3B
YoY-9.6%
43.5B
YoY-1.2%
44.0B
YoY-7.7%
47.7B
YoY-5.9%
13.5B
YoY+5.2%
12.8B
YoY+4.5%
12.2B
YoY+6.8%
11.5B
YoY+4.0%
11.0B
YoY-16.2%
32.8B
YoY-2.3%
33.6B
YoY-4.9%
35.4B
YoY-0.2%
35.4B
YoY-2.8%
36.4B
YoY-8.0%
7.91B
YoY+47.2%
5.37B
YoY-28.4%
7.51B
YoY-3.8%
7.80B
YoY-24.1%
10.3B
YoY+2.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.65B
YoY+32.2%
1.25B
YoY-8.8%
1.37B
YoY-14.0%
1.59B
YoY+99.2%
798M
YoY-34.4%
737M
YoY-6.9%
792M
YoY-18.2%
968M
YoY+47.6%
656M
YoY-56.9%
1.52B
YoY+76.5%
-2.15B
YoY-20.1%
-1.79B
YoY+6.4%
-1.91B
YoY-28.6%
-1.49B
YoY+31.5%
-2.17B
YoY-15.2%
FX effect on cash
21.0M
YoY+112.1%
-174M
YoY-480.0%
-30.0M
YoY+75.6%
-123M
YoY+3.9%
-128M
YoY-1700.0%
Net change in cash
256M
YoY+245.9%
74.0M
YoY-81.2%
393M
YoY-38.2%
636M
YoY+2928.6%
21.0M
YoY-89.6%
Interest paid
950M
YoY-5.4%
1.00B
YoY-6.9%
1.08B
YoY+13.7%
948M
YoY+3.8%
913M
YoY+7.9%
Income taxes paid
471M
YoY+58.1%
298M
YoY-45.1%
543M
YoY+9.7%
495M
YoY-30.2%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
35.9B
YoY+43.6%
25.0B
YoY+113.5%
11.7B
YoY+15.5%
10.1B
YoY+14.6%
8.84B
YoY-16.5%
P/E
25.5×
21.2×
P/S
2.1×
YoY+37.7%
1.5×
YoY+97.1%
0.8×
YoY+14.5%
0.7×
YoY+20.2%
0.6×
YoY-12.4%
P/B
4.5×
YoY-2.5%
4.7×
YoY+175.4%
1.7×
YoY+46.2%
1.2×
YoY+34.4%
0.9×
YoY-18.5%
P/FCF
31.3×
YoY-6.3%
33.4×
YoY+73.3%
19.2×
YoY-2.3%
19.7×
YoY-47.4%
37.4×
YoY+125.8%
3.9%
4.7%
3.2%
YoY+6.7%
3.0%
YoY-42.3%
5.2%
YoY+2.4%
5.1%
YoY+90.0%
2.7%
YoY-55.7%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TEVA's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TEVA filings on SEC EDGAR → Not investment advice.